← Back to Patent Explorer
US4716179A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of non-irritating or slightly irritating and/or promoting diterpene alcohol and of derivatives thereof as antineoplastic preparations

Assignee: German Cancer Research Center
•
Filing: 1984-02-29
•
Granted: 1987-12-29
•
Expires: 2004-02-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is directed to a method of inhibiting the growth of cancer cells in a lower animal host through the use of phorbol.

Inventors

  • 👤 Erich Hecker
  • 👤 Hans Osswald
  • 👤 Rainer Schmidt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:54
CPC Classifications
C; C07; C07C; C07C49/00; C07C49/587; C07C49/703; C07C49/723; C07C49/727; A; A61; A61P; A61P31/00; A61P31/04; C07C49/743

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 29 words
The method of treating transplanted tumor-afflicted animal subjects which comprises administering to said subjects an anti-transplanted tumor effective amount of phorbol, said phorbol being incorporated in a carrier material.
Claim 2
Independent Claim 29 words
The method of treating transplanted tumor-afflicted animal subjects which comprises administering to said subjects an anti-transplanted tumor effective amount of phorbol, said phorbol being incorporated in a carrier material.
Claim 3
Dependent Claim 25 words
The method of claim 1, wherrein said carrier material is selected from the group consisting of polyethylene glycol, ethanol, sesame oil, cremophor and isopropyl myristate.
Claim 4
Independent Claim 34 words
The method of treating transplanted tumor-afflicted animal subjects, which comprises administering to said subjects phorbol in a weekly dose lower than 20% of the DL 50, said phorbol being incorporated in a carrier material.
Claim 5
Independent Claim 34 words
The method of treating transplanted tumor-afflicted animal subjects, which comprises administering to said subjects phorbol in a weekly dose lower than 20% of the DL 50, said phorbol being incorporated in a carrier material.
Claim 6
Dependent Claim 25 words
The method of claim 3, wherein said carrier material is selected from the group consisting of polyethylene glycol, ethanol, sesame oil, Cremophor and isopropyl myristate.
Claim 7
Independent Claim 40 words
A method for inhibiting the growth of cancer cells in a lower animal host which comprises the administration to the host of a cancer cell growth-inhibiting effective amount of a pharmaceutical composition which comprises phorbol and a pharmaceutically acceptable carrier.
Claim 8
Independent Claim 40 words
A method for inhibiting the growth of cancer cells in a lower animal host which comprises the administration to the host of a cancer cell growth-inhibiting effective amount of a pharmaceutical composition which comprises phorbol and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 24 words
The method of claim 5 wherein said carrier is selected from the group consisting of polyethylene glycol, ethanol, sesame oil, cremophor and isopropyl myristate.
Claim 10
Dependent Claim 20 words
The method of claim 5 wherein a weekly dose of phorbol lower than 20% of the DL 50 is administered.
Claim 11
Dependent Claim 20 words
The method of claim 6 wherein a weekly dose of phorbol lower than 20% of the DL 50 is adminitered.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-12-28 1991-06-29 1991-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-12-28 1995-06-29 1995-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-12-28 1999-06-29 1999-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag